HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression

Documenti analoghi

• Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register‐based study
  di: Dina Overgaard Eriksen, et al.
  Pubblicazione: (2024)
• Correction to “ HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression”EriksenDO, KrogL, OstenfeldEB, et al. HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression. Acta Obstet Gynecol Scand. 2026;105(2):377–385. doi:10.1111/aogs.70128.
  di: Dina Overgaard Eriksen
  Pubblicazione: (2026)
• Discontinuation of cervical cancer screening for HPV‐vaccinated women?
  di: Jesper Bonde, et al.
  Pubblicazione: (2024)
• High rate of persistent HPV detection after diagnostic cervical excision in older screen‐positive women
  di: Line Winther Gustafson, et al.
  Pubblicazione: (2025)
• Survey of practices in the European Federation for Colposcopy: HPV vaccination after treatment for cervical precancerous lesions
  di: Annu Heinonen, et al.
  Pubblicazione: (2025)